Endomatrix Inc

Industry:	Pharmaceuticals, Biotechnology
Revenues:	Under $20 Million

Description

Endomatrix, Inc., has developed a breakthrough platform for the treatment and prevention of endothelial-based disease states, focusing on the root cause of disease rather than the symptoms. Founded in 2000, Endomatrix is focused on delivering its platform to a global audience through both nutraceutical and pharmaceutical products. Endomatrix is based in Santa Rosa, California and has an office in Barcelona, Spain.